Shree Ganesh Bio-Tech Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
For the full year, revenue was INR 213.34 million compared to INR 630.19 million a year ago. Net income was INR 6.21 million compared to INR 20.39 million a year ago. Basic earnings per share from continuing operations was INR 0.02 compared to INR 0.05 a year ago. Diluted earnings per share from continuing operations was INR 0.02 compared to INR 0.05 a year ago.